These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16718271)

  • 61. Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma.
    Nuzzo C; Zeuli M; Ferraresi V; Ciccarese M; Pelligrini D; Cognetti F
    Anticancer Res; 2008; 28(2B):1429-31. PubMed ID: 18505091
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High-dose vincristine sulfate liposome injection (Marqibo) Is not associated with clinically meaningful hematologic toxicity.
    Deitcher OR; Glaspy J; Gonzalez R; Sato T; Bedikian AY; Segarini K; Silverman J; Deitcher SR
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):197-202. PubMed ID: 24417913
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
    Li EX; Zhang YT; Shang JT; Xu Z; Geng Y; Li SM; Shi F; Wu YY
    Ai Zheng; 2006 Aug; 25(8):1048-51. PubMed ID: 16965692
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma.
    Martín-Algarra S; Espinosa E; Rubió J; López López JJ; Manzano JL; Carrión LA; Plazaola A; Tanovic A; Paz-Ares L
    Eur J Cancer; 2009 Mar; 45(5):732-5. PubMed ID: 19186051
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of metastatic malignant melanoma with dacarbazine and cisplatin.
    Oratz R; Speyer JL; Green M; Blum R; Wernz JC; Muggia FM
    Cancer Treat Rep; 1987 Sep; 71(9):877-8. PubMed ID: 3621224
    [No Abstract]   [Full Text] [Related]  

  • 66. [Chemoimmunotherapy with dacarbazine and aranose combined with interferon-alpha in disseminated cutaneous melanoma].
    Gershanovich ML; Akimov MA
    Vopr Onkol; 2004; 50(2):179-83. PubMed ID: 15176220
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma.
    Terheyden P; Bröcker EB; Becker JC
    J Cancer Res Clin Oncol; 2004 Jul; 130(7):395-9. PubMed ID: 15160290
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treosulfan and gemcitabine.
    Cree IA; Neale MH; Reinhold U; Kurbacher CM
    J Cancer Res Clin Oncol; 2005 May; 131(5):329-30; author reply 331. PubMed ID: 15700153
    [No Abstract]   [Full Text] [Related]  

  • 69. Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors.
    Némati F; Sastre-Garau X; Laurent C; Couturier J; Mariani P; Desjardins L; Piperno-Neumann S; Lantz O; Asselain B; Plancher C; Robert D; Péguillet I; Donnadieu MH; Dahmani A; Bessard MA; Gentien D; Reyes C; Saule S; Barillot E; Roman-Roman S; Decaudin D
    Clin Cancer Res; 2010 Apr; 16(8):2352-62. PubMed ID: 20371695
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.
    Carvajal RD; Sosman JA; Quevedo JF; Milhem MM; Joshua AM; Kudchadkar RR; Linette GP; Gajewski TF; Lutzky J; Lawson DH; Lao CD; Flynn PJ; Albertini MR; Sato T; Lewis K; Doyle A; Ancell K; Panageas KS; Bluth M; Hedvat C; Erinjeri J; Ambrosini G; Marr B; Abramson DH; Dickson MA; Wolchok JD; Chapman PB; Schwartz GK
    JAMA; 2014 Jun; 311(23):2397-405. PubMed ID: 24938562
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes.
    Binkley E; Triozzi PL; Rybicki L; Achberger S; Aldrich W; Singh A
    Br J Ophthalmol; 2020 Apr; 104(4):524-528. PubMed ID: 31371315
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A phase II study of bendamustine chemotherapy as second-line treatment in metastatic uveal melanoma.
    Schmidt-Hieber M; Schmittel A; Thiel E; Keilholz U
    Melanoma Res; 2004 Dec; 14(6):439-42. PubMed ID: 15577312
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bleomycin, carmustine, vincristine, and dacarbazine in patients with metastatic malignant melanoma.
    Cohen SM; Ohnuma T; Cheung T; Holland JF
    Cancer Treat Rep; 1983 Oct; 67(10):947-8. PubMed ID: 6194881
    [No Abstract]   [Full Text] [Related]  

  • 74. Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma: multicenter, retrospective analysis in Asia.
    Yi JH; Yi SY; Lee HR; Lee SI; Lim DH; Kim JH; Park KW; Lee J
    Melanoma Res; 2011 Jun; 21(3):223-7. PubMed ID: 21471822
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib.
    Niederkorn A; Wackernagel W; Artl M; Schwantzer G; Aigner B; Richtig E
    Acta Ophthalmol; 2014 Dec; 92(8):e696-7. PubMed ID: 24774993
    [No Abstract]   [Full Text] [Related]  

  • 76. Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study.
    Jespersen H; Olofsson Bagge R; Ullenhag G; Carneiro A; Helgadottir H; Ljuslinder I; Levin M; All-Eriksson C; Andersson B; Stierner U; Nilsson LM; Nilsson JA; Ny L
    BMC Cancer; 2019 May; 19(1):415. PubMed ID: 31046743
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Medical treatment of uveal melanoma.
    Queirolo P; Acquati M
    Tumori; 2007; 93(3):suppl 27-30. PubMed ID: 17679486
    [No Abstract]   [Full Text] [Related]  

  • 79. Treosulfan in the treatment of metastatic melanoma: from chemosensitivity testing to clinical trials.
    Neuber K
    Recent Results Cancer Res; 2003; 161():159-79. PubMed ID: 12528807
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dose-response relationship to dacarbazine demonstrated in a patient with malignant melanoma.
    Hoelzer KL; Harrison BR; Luedke DW; Mahanta B
    Cancer Treat Rep; 1986 Oct; 70(10):1211-2. PubMed ID: 3756941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.